ERBB2 and breast cancer: The protein expression of HER2 (encoded by ERBB2) is routinely used as a predictive marker for targeted therapy in BC [31]; therefore, the frequent overexpression of ERBB2 transcripts in CTCs of patients with HER2- primary tumors, in line with previous results [12,32], might be relevant for treatment management in the future.